The Effects of Chronic Psychostimulant Administration on Bone Health: A Review
2024
Jessica Nowak | Jacob Aronin | Faraaz Beg | Natasha O’Malley | Michael Ferrick | Teresa Quattrin | Sonja Pavlesen | Michael Hadjiargyrou | David E. Komatsu | Panayotis K. Thanos
(1) Background: Methylphenidate (MP) and amphetamine (AMP) are psychostimulants that are widely prescribed to treat Attention Deficit Hyperactivity Disorder (ADHD) and narcolepsy. In recent years, 6.1 million children received an ADHD diagnosis, and nearly 2/3 of these children were prescribed psychostimulants for treatment. The purpose of this review is to summarize the current literature on psychostimulant use and the resulting effects on bone homeostasis, biomechanical properties, and functional integrity. (2) Methods: Literature searches were conducted from Medline/PubMed electronic databases utilizing the search terms “methylphenidate” OR “amphetamine” OR “methylphenidate” AND “bone health” AND “bone remodeling” AND “osteoclast” AND “osteoblast” AND “dopamine” from 01/1985 to 04/2023. (3) Results: Of the 550 publications found, 44 met the inclusion criteria. Data from identified studies demonstrate that the use of MP and AMP results in decreases in specific bone properties and biomechanical integrity via downstream effects on osteoblasts and osteoclast-related genes. (4) Conclusions: The chronic use of psychostimulants negatively affects bone integrity and strength as a result of increased osteoclast activity. These data support the need to take this into consideration when planning the treatment type and duration for bone fractures.
显示更多 [+] 显示较少 [-]